Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-16-007869
Filing Date
2016-03-07
Accepted
2016-03-07 16:58:49
Documents
1
Period of Report
2016-03-04

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 5511
  Complete submission text file 0001493152-16-007869.txt   6979
Mailing Address 2980 BEVERLY GLEN CIRCLE SUITE 301 LOS ANGELES CA 90077
Business Address 2980 BEVERLY GLEN CIRCLE SUITE 301 LOS ANGELES CA 90077 310-474-9809
Targeted Medical Pharma, Inc. (Issuer) CIK: 0001420030 (see all company filings)

EIN.: 205863618 | Fiscal Year End: 1209
SIC: 2834 Pharmaceutical Preparations

Mailing Address TARGETED MEDICAL PHARMA, INC. 2980 BEVERLY GLEN CIRCLE, SUITE 301 LOS ANGELES CA 90077
Business Address
Giffoni Kim (Reporting) CIK: 0001509563 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-53071 | Film No.: 161489173